Hiba Zayyad

ORCID: 0000-0003-2844-5696
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Long-Term Effects of COVID-19
  • COVID-19 Clinical Research Studies
  • Antibiotic Resistance in Bacteria
  • COVID-19 and Mental Health
  • SARS-CoV-2 and COVID-19 Research
  • Antibiotics Pharmacokinetics and Efficacy
  • Pneumonia and Respiratory Infections
  • COVID-19 and healthcare impacts
  • Viral Infections and Vectors
  • Intensive Care Unit Cognitive Disorders
  • Sepsis Diagnosis and Treatment
  • Vaccine Coverage and Hesitancy
  • Bacterial Identification and Susceptibility Testing
  • Antibiotic Use and Resistance
  • Clinical Reasoning and Diagnostic Skills
  • Vector-borne infectious diseases
  • Mosquito-borne diseases and control
  • Urinary Tract Infections Management
  • Psychological Well-being and Life Satisfaction
  • Respiratory Support and Mechanisms
  • Vibrio bacteria research studies
  • Neurological diseases and metabolism
  • Nuclear Receptors and Signaling
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Burkholderia infections and melioidosis

Bar-Ilan University
2021-2024

Poriya Medical Center
2019-2024

Azrieli College of Engineering Jerusalem
2023

All India Institute of Medical Sciences Raipur
2023

All India Institute of Medical Sciences Rishikesh
2023

Institut de Recherche Vaccinale
2022

Rambam Health Care Campus
2017-2021

University of Oxford
2021

Infectious Diseases Institute
2018

Hadassah Medical Center
2013

Gram-negative bacteremia is a major cause of morbidity and mortality in hospitalized patients. Data to guide the duration antibiotic therapy are limited.This was randomized, multicenter, open-label, noninferiority trial. Inpatients with gram-negative bacteremia, who were afebrile hemodynamically stable for at least 48 hours, randomized receive 7 days (intervention) or 14 (control) covering therapy. Patients uncontrolled focus infection excluded. The primary outcome 90 composite all-cause...

10.1093/cid/ciy1054 article EN Clinical Infectious Diseases 2018-12-07

Abstract The effectiveness of Coronavirus disease 2019 (COVID-19) vaccines against the long-term COVID-19 symptoms expressed by a substantial proportion patients is not well understood. We determined whether vaccination with BNT162b2 mRNA vaccine was associated incidence reporting post-SARS-CoV-2 infection. invited individuals PCR-tested for SARS-CoV-2 infection at participating hospitals between March 2020 and November 2021 to fill an online questionnaire that included information about...

10.1038/s41541-022-00526-5 article EN cc-by npj Vaccines 2022-08-26

Abstract Background Long COVID is a post-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection characterised by not recovering for several weeks or months following the episode. The effectiveness of COVID-19 vaccines against long-term symptoms well understood. We determined whether vaccination was associated with incidence reporting post-SARS-CoV-2 Methods invited individuals who were PCR tested SARS-CoV-2 at participating hospitals between March 2020-November 2021 to fill...

10.1101/2022.01.05.22268800 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-01-06

Abstract Background We evaluated the association between mortality and colistin resistance in Acinetobacter baumannii infections interaction with antibiotic therapy. Methods This is a secondary analysis of randomized controlled trial patients carbapenem-resistant gram-negative bacterial treated or colistin-meropenem combination. infection caused by A. (CRAB) identified as susceptible (CoS) at time treatment compared which isolate was confirmed CoS those whose isolates were retrospectively...

10.1093/cid/ciy988 article EN Clinical Infectious Diseases 2018-11-15
Ali Abbas Sheryl Ann Abdukahil Nurul Najmee Abdulkadir Ryuzo Abe Laurent Abel and 95 more Lara Absil Kamal Abu Jabal Hiba Zayyad Subhash Acharya Andrew Acker Shingo Adachi Elisabeth Adam Enrico Adriano Diana Adrião Saleh Al Ageel Shakeel Ahmed Marina Aiello Kate Ainscough Eka Airlangga Tharwat Aisa Ali Ait Hssain Younes Ait Tamlihat Takako Akimoto Ernita Akmal Eman Al Qasim Tala Al-dabbous Abdulrahman Al‐Fares Razi Alalqam Angela Alberti Senthilkumar Alegesan Cynthia Alegre Marta Alessi Beatrice Alex Kévin Alexandre Huda Alfoudri Adam Ali Imran Ali Naseem Ali Shah Naseem Ali Sheikh Kazali Enagnon Alidjnou Jeffrey Aliudin Qabas Alkhafajee Clotilde Allavena Nathalie Allou Aneela Altaf João Alves João Alves Rita C. Alves Maria João Amaral Nur Amira Heidi S. M. Ammerlaan Phoebe Ampaw Roberto Andini Claire Andréjak Andrea Angheben François Angoulvant Séverine Ansart Sivanesen Anthonidass Massimo Antonelli Carlos Alexandre Antunes de Brito Kazi Rubayet Anwar Ardiyan Apriyana Yaseen M. Arabi Irene Aragão Francisco Arancibia Carolline Araujo Antonio Arcadipane Patrick Archambault Lukas Arenz Jean‐Benoît Arlet Christel Arnold-Day Ana Aroca Lovkesh Arora Rakesh C. Arora Élise Artaud-Macari Diptesh Aryal Motohiro Asaki Ángel Asensio Elizabeth A. Ashley Muhammad Ashraf Namra Asif Mohammad Asim Jean‐Baptiste Assié Amirul Asyraf Anika Atique A. M. Udara Lakshan Attanyake Johann Auchabie Hugues Aumaître Adrien Auvet Eyvind W. Axelsen Laurène Azemar Cécile Azoulay Benjamin Bach Delphine Bachelet Claudine Badr Roar Bævre-Jensen Nadia Baig J. Kenneth Baillie J. Kevin Baird Erica Bak

Abstract The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 dataset is one of the largest international databases prospectively collected clinical data on people hospitalized with COVID-19. This was compiled during pandemic by a network hospitals that collect using ISARIC-World Health Organization Clinical Characterization Protocol tools. database includes from more than 705,000 patients, in 60 countries 1,500 centres worldwide. Patient are...

10.1038/s41597-022-01534-9 article EN cc-by Scientific Data 2022-07-30

<h3>Importance</h3> Despite the high 3-dose vaccination rate among health care workers (HCWs) in Israel, a of SARS-CoV-2 breakthrough infections this group was observed during Omicron wave. As result, Israeli Ministry Health decided to recommend fourth vaccine dose medical staff. <h3>Objective</h3> To evaluate benefit BNT162b2 on infection HCWs. <h3>Design, Setting, and Participants</h3> This multicenter cohort study performed January 2022, first month 4-dose campaign, surge variant All at...

10.1001/jamanetworkopen.2022.24657 article EN cc-by-nc-nd JAMA Network Open 2022-08-02
Sung‐Min Cho Lavienraj Premraj Denise Battaglini Jonathon P. Fanning Jacky Y. Suen and 95 more Gianluigi Li Bassi John F. Fraser Chiara Robba Matthew Griffee Tom Solomon Malcolm G. Semple J. Kenneth Baillie Louise Sigfrid J. T. Scott Barbara Wanjiru Citarella Laura Merson Rakesh C. Arora Glenn Whitman David Thomson Nicole White Laurent Abel Amal Abrous Kamal Abu Jabal Hiba Zayyad Younes Ait Tamlihat Aliya Mohammed Alameen Marta Alessi Beatrice Alex Kévin Alexandre Adam A. Ali Kazali Enagnon Alidjnou Clotilde Allavena Nathalie Allou Claire Andréjak Andrea Angheben François Angoulvant Séverine Ansart Jean‐Benoît Arlet Élise Artaud-Macari Jean‐Baptiste Assié Johann Auchabie Hugues Aumaître Adrien Auvet Eyvind W. Axelsen Laurène Azemar Cécile Azoulay Benjamin Bach Delphine Bachelet Claudine Badr Roar Bævre-Jensen J. Kenneth Baillie Firouzé Bani‐Sadr William Barclay Marie Bartoli Joaquín Baruch Romain Basmaci Jules Bauer Alexandra Bedossa Husna Begum Sylvie Behilill Anna Beltrame Marine Beluze Nicolas Benech Delphine Bergeaud José Luis Bernal Sobrino Giulia Bertoli Simon Bessis Sybille Bevilcaqua Karine Bezulier Krishna Bhavsar Zeno Bisoffi Laurent Bitker Mathieu Blot Laetitia Bodénes Debby Bogaert Anne-Hélène Boivin Isabela Bolaños Pierre-Adrien Bolze François Bompart Raphaël Borie Élisabeth Botelho-Nevers Lila Bouadma Olivier Bouchaud Sabelline Bouchez Damien Bouhour Kévin Bouiller Laurence Bouillet Camile Bouisse Anne‐Sophie Boureau Maude Bouscambert Aurore Bousquet Marielle Boyer-Besseyre Axelle Braconnier Sonja Hjellegjerde Brunvoll Marielle Buisson Danilo Buonsenso Aidan Burrell Ingrid G. Bustos André Cabié Eder Cáceres

Abstract Although it is known that coronavirus disease 2019 can present with a range of neurological manifestations and in-hospital complications, sparse data exist on whether these initial symptoms are closely associated post-acute sequelae SARS-CoV-2 (severe acute respiratory syndrome 2; PANSC) female versus male sex impacts symptom resolution. In this international, multi-centre, prospective, observational study across 407 sites from 15 countries (30 January 2020 to 30 April 2022), we...

10.1093/braincomms/fcae036 article EN cc-by Brain Communications 2024-01-01

Colistin heteroresistance (HR) refers to a bacterial population comprised of several subpopulations with different levels resistance colistin. In this study, we discuss the classic form HR, in which resistant subpopulation exists within predominantly susceptible population. We investigated prevalence colistin HR and its evolution into full among 173 clinical carbapenem-resistant Acinetobacter baumannii isolates examined effect on outcomes. To determine performed analysis profiling. Our...

10.1128/spectrum.05093-22 article EN cc-by Microbiology Spectrum 2023-05-23

The impact of Coronavirus disease-2019 (COVID-19) extends beyond health, potentially affecting long-term income and employment dynamics. In Israel, disparities exist between Jewish Arab populations across many dimensions, including socioeconomic. study's primary aim was to compare changes in among COVID-19-infected non-infected participants Jews Arabs, the two main population groups comprising Israel. We conducted a cross-sectional study March 2021 June 2022 adults employed prior pandemic,...

10.1186/s12889-025-22426-8 article EN cc-by-nc-nd BMC Public Health 2025-03-31

Abstract Background Empirical colistin should be avoided. We aimed to evaluate the association between covering empirical antibiotics (EAT) and mortality for infections caused by carbapenem-resistant gram-negative bacteria (CRGNB). Methods This was a secondary analysis of randomized controlled trial, including adults with bloodstream infections, pneumonia, or urosepsis CRGNB. All patients received EAT followed targeted therapy. The exposure variable in first 48 hours. outcome 28-day...

10.1093/cid/ciy371 article EN Clinical Infectious Diseases 2018-04-25

Investigating the effect of different face masks on dry eye disease (DED) among healthcare workers during COVID-19 pandemic.This was a comparative, cross-sectional study. Participants were included into two groups: group 1 (n = 30) wore surgical masks, and 2 N95 with shields. Demographic ocular surface index questionnaires (OSDI) performed. In addition, Tear break-up time (TBUT), corneal conjunctival fluorescein staining, meibography to assess meibomian gland loss (MGL) performed all...

10.4103/ijo.ijo_1133_21 article EN cc-by-nc-sa Indian Journal of Ophthalmology 2022-02-25

We evaluated whether carbapenem-colistin combination therapy reduces the emergence of colistin resistance, compared to monotherapy, when given patients with infections due carbapenem-resistant Gram-negative organisms.This is a pre-planned analysis secondary outcome from randomized, controlled trial comparing monotherapy colistin-meropenem for treatment severe caused by carbapenem-resistant, colistin-susceptible bacteria. rectal swabs taken on Day 7 or later presence new colistin-resistant...

10.1093/cid/ciz1146 article EN Clinical Infectious Diseases 2019-11-21

The association between Body Mass Index (BMI) and clinical outcomes following sepsis continues to be debated. We aimed investigate the relationship BMI in-hospital course mortality in patients hospitalized with bacteremic using real-world data. A sampled cohort of October 2015 December 2016 was identified National Inpatient Sample (NIS) database. In-hospital length stay were defined as relevant outcomes. Patients divided into 6 (kg/m2) subgroups; (1) underweight ≤ 19, (2) normal-weight...

10.3390/jcm12113848 article EN Journal of Clinical Medicine 2023-06-04

Optimal treatment of carbapenem-resistant Gram-negative bacteria (CR-GNB) infections is uncertain because the lack good-quality evidence and limited effectiveness available antibiotics. The aim this survey was to investigate clinicians' prescribing strategies for treating CR-GNB worldwide.A 36-item questionnaire developed addressing following aspects antibiotic prescribing: respondent's background, diagnostic therapeutic availability, preferred rationale selecting combination therapy....

10.1016/j.cmi.2021.05.002 article EN cc-by-nc-nd Clinical Microbiology and Infection 2021-05-09

Abstract In a multicenter, nationwide, retrospective study of patients hospitalized with spotted fever group rickettsiosis in Israel during 2010–2019, we identified 42 cases, which 36 were autochthonous. The most prevalent species was the Rickettsia conorii Israeli tick typhus strain (n = 33, 79%); infection this necessitated intensive care for 52% and associated 30% fatality rate. A history bite rare, found only 5% patients; eschar 12%; leukocytosis more common than leukopenia. Most (72%)...

10.3201/eid2708.203661 article EN cc-by Emerging infectious diseases 2021-08-01

Parkinson's disease is a progressive neurodegenerative disorder, where most cases are sporadic with late onset. In rare incidences familial forms of early-onset parkinsonism occur, and when recessively inherited, often explained by mutations in either the parkin (PARK2) or PINK1 (PARK6) gene on exceptional occasions DJ-1 (PARK7) ATP13A2 (PARK9) gene. Recessively inherited deletions/duplications point common cause known so far, but an increasing number studies, genetic variations...

10.1186/1471-2377-8-47 article EN cc-by BMC Neurology 2008-12-01

The clinical features of spotted fever group (SFG) Rickettsia induced disease range from a mild to severe illness. complexity is even greater due the fact that can be caused by different species with varying degrees virulence. Current knowledge asserts Israeli SFG (ISF) strain conorii israelensis only human pathogenic member in Israel. diagnostic procedures distinguish between and typhus rickettsiosis, assuming all SFG-positive samples positive for ISF. Molecular studies on questing ticks...

10.3390/pathogens9010011 article EN cc-by Pathogens 2019-12-20

Background Changing patterns of vaccine breakthrough can clarify effectiveness. Aim To compare infections during a SARS-CoV-2 Delta wave vs unvaccinated inpatients, and an earlier Alpha wave. Methods In observational multicentre cohort study in Israel, hospitalised COVID-19 patients were divided into three cohorts: Comirnaty-vaccinated (VD; Jun–Aug 2021) cases the (ND) (VA; Jan–Apr 2021). Primary outcome was death or ventilation. Results We included 343 VD, 162 ND 172 VA patients. VD more...

10.2807/1560-7917.es.2022.27.20.2101026 article EN cc-by Eurosurveillance 2022-05-19

Abstract Background Population external validity is the extent to which an experimental study results can be generalized from a specific sample defined population. In order apply of study, we should able assess its population validity. We performed investigator-initiated randomized controlled trial (RCT) (AIDA study), compared colistin-meropenem combination therapy colistin monotherapy in treatment patients infected with carbapenem-resistant Gram-negative bacteria. examine study’s and...

10.1186/s12879-021-05995-y article EN cc-by BMC Infectious Diseases 2021-03-31

The impact of individual symptoms reported post-COVID-19 on subjective well-being (SWB) is unknown. We described associations between SWB and selected following SARS-CoV-2 infection. analysed well being from 2295 participants (of which 576 reporting previous infection) in an ongoing longitudinal cohort study taking place Israel. estimated changes associated with at three follow-up time points (3-6, 6-12 12-18 months post among infection, adjusted for key demographic variables, using linear...

10.1017/s0950268822001996 article EN cc-by-nc-nd Epidemiology and Infection 2023-01-01
Coming Soon ...